Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Sponsor: Ulthera, Inc
Terminated
The study data to date show the required primary study endpoint will not be met.
Other terminated trials from Ulthera, Inc
- Skin Laxity · Phase NA · Aug 2016
- Peri-oral Wrinkles · Phase NA · Aug 2014
- Surgical Scar · Phase NA · Feb 2014
- Primary Axillary Hyperhidrosis · Phase NA · Nov 2013
- Skin Laxity · Phase NA · Oct 2013
More terminations from Ulthera, Inc
Other Skin Laxity trials with similar outcome
This NA trial investigates Skin Laxity and is currently terminated or withdrawn. Ulthera, Inc leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Mar 2020 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Mar 2020 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Terminated NA
-
Aug 2017 — Feb 2018 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jun 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ulthera, Inc
For direct contact, visit the study record on ClinicalTrials.gov .